Escitalopram in anxiety associated COPD exacerbations

• Research type

  Research Study

• Full title

  The effect of Escitalopram on exacerbation rates and quality of life in patients with anxiety associated severe COPD; a pilot study.

• IRAS ID

  91103

• Contact name

  Alyn Morice

• Contact email

  a.h.morice@hull.ac.uk

• Sponsor organisation

  Hull and East Yorkshire Hospitals NHS Trust

• Eudract number

  2010-022038-10

• Clinicaltrials.gov Identifier

  NCT01522092

• Duration of Study in the UK

  1 years, 10 months, 21 days

• Research summary

  This study is to determine whether patients with severe COPD,and symptoms indicative of anxiety, regularly admitted in to hospital with exacerbation, when treated with escatilopram have a reduced number of exacerbations.

• REC name

  Yorkshire & The Humber - Leeds West Research Ethics Committee

• REC reference

  15/YH/0216

• Date of REC Opinion

  14 May 2015

• REC opinion

  Unfavourable Opinion